Skip to main content
Log in

Pharmacokinetics of bretylium in man after intravenous administration

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The pharmacokinetic profile of bretylium was studied in four normal male volunteers using a new sensitive EC-GC procedure for its quantitation in biological fluids. The plasma concentrations and urinary excretion rates following the constant i.v. infusion of a single 4mg/kg dose of bretylium tosylate declined biexponentially and the data were fitted to a two-compartment model with a renal and a nonrenal route of elimination. The drug had a mean half-life (t1/2β)of 7.8 hr and apparent volume of distribution (Vd,β)of 8.18 liters/kg. The renal clearance, which was 6 times that of the glomerular filtration rate, accounted for almost 84% of the total body clearance and correlated linearly with the subjects' creatinine clearance. The observed side effects of bretylium were mild and similar to those of other adrenergic blocking agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. A. L. A. Boura and A. F. Green. Darenthin: Hypotensive agent of new type.Lancet 2:17–21 (1959.

    CAS  PubMed  Google Scholar 

  2. M. B. Bacaner. Bretylium tosylate for suppression of induced ventricular fibrillation.Am. J. Cardiol. 17:528–534 (1966).

    Article  CAS  PubMed  Google Scholar 

  3. C. T. Dollery, D. Emslie-Smith, and J. McMichael. Bretylium tosylate in the treatment of hypertension.Lancet 1:296–299 (1960).

    Article  CAS  PubMed  Google Scholar 

  4. W. G. Duncombe and A. McCoubrey. The excretion and stability to metabolism of bretylium.Br. J. Pharmacol. 15:260–264 (1960).

    CAS  Google Scholar 

  5. R. Kuntzman, I. Tsai, R. Chang, and A. H. Conney. Disposition of bretylium in man and rat: A sensitive chemical method for its estimation in plasma and urine.Clin. Pharmacol. Ther. 11:829–837 (1970).

    CAS  PubMed  Google Scholar 

  6. J. Koch-Weser. Drug therapy: Bretylium.New Engl. J. Med. 300:473 (1979).

    Article  CAS  PubMed  Google Scholar 

  7. J. Adir, P. K. Narang, J. Josselson, and J. Sadler. Pharmacokinetics of bretylium in patients with impaired renal function.New Engl. J. Med. 300:1390–1391 (1979).

    Article  CAS  PubMed  Google Scholar 

  8. C. M. Lai, B. L. Kamath, J. E. Carter, P. Erhardt, Z. M. Look, and A. Yacobi. Determination of bretylium in biological fluids. Personal communication.

  9. Berman and Weiss.SAAM Manual, U.S. Department of Health, Education, and Welfare, Washington, D.C., 1978.

    Google Scholar 

  10. H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff. Statistical estimations in pharmacokinetics.J. Pharmacokin. Biopharm. 2:123–148 (1974).

    Article  CAS  Google Scholar 

  11. C. Daniel and F. S. Wood.Fitting Equations to Data, Wiley-Interscience, New York, 1971.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by a grant from Arnar-Stone Laboratories, Inc., McGaw Park, Illinois.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Narang, P.K., Adir, J., Josselson, J. et al. Pharmacokinetics of bretylium in man after intravenous administration. Journal of Pharmacokinetics and Biopharmaceutics 8, 363–372 (1980). https://doi.org/10.1007/BF01059384

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01059384

Key words

Navigation